nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—CYP1A1—Dacarbazine—sarcoma	0.0872	0.126	CbGbCtD
Acetaminophen—UGT1A1—Etoposide—sarcoma	0.0841	0.121	CbGbCtD
Acetaminophen—CYP2E1—Dacarbazine—sarcoma	0.0674	0.0972	CbGbCtD
Acetaminophen—CYP2E1—Mitoxantrone—sarcoma	0.0523	0.0754	CbGbCtD
Acetaminophen—PTGS2—Etoposide—sarcoma	0.0505	0.0729	CbGbCtD
Acetaminophen—PTGS1—Etoposide—sarcoma	0.0427	0.0616	CbGbCtD
Acetaminophen—CYP1A2—Dacarbazine—sarcoma	0.039	0.0562	CbGbCtD
Acetaminophen—CYP3A4—Thiotepa—sarcoma	0.0368	0.0532	CbGbCtD
Acetaminophen—CYP2E1—Etoposide—sarcoma	0.033	0.0476	CbGbCtD
Acetaminophen—ABCB1—Dactinomycin—sarcoma	0.0295	0.0426	CbGbCtD
Acetaminophen—ABCB1—Mitoxantrone—sarcoma	0.0264	0.0381	CbGbCtD
Acetaminophen—CYP2C8—Etoposide—sarcoma	0.0246	0.0355	CbGbCtD
Acetaminophen—CYP1A2—Etoposide—sarcoma	0.0191	0.0275	CbGbCtD
Acetaminophen—TRPV1—sciatic nerve—sarcoma	0.0184	0.17	CbGeAlD
Acetaminophen—ABCB1—Vincristine—sarcoma	0.0182	0.0263	CbGbCtD
Acetaminophen—ABCB1—Etoposide—sarcoma	0.0167	0.0241	CbGbCtD
Acetaminophen—CYP3A4—Mitoxantrone—sarcoma	0.0158	0.0229	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—sarcoma	0.0114	0.0164	CbGbCtD
Acetaminophen—CYP3A4—Vincristine—sarcoma	0.0109	0.0157	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—sarcoma	0.0107	0.0155	CbGbCtD
Acetaminophen—CYP3A4—Etoposide—sarcoma	0.00999	0.0144	CbGbCtD
Acetaminophen—CYP3A4—Doxorubicin—sarcoma	0.00681	0.00983	CbGbCtD
Acetaminophen—CNR1—mammary gland—sarcoma	0.00467	0.0431	CbGeAlD
Acetaminophen—UGT2B15—mammary gland—sarcoma	0.00414	0.0383	CbGeAlD
Acetaminophen—SULT2A1—hematopoietic system—sarcoma	0.00329	0.0304	CbGeAlD
Acetaminophen—SULT1E1—hematopoietic system—sarcoma	0.00304	0.0281	CbGeAlD
Acetaminophen—SULT1A1—seminal vesicle—sarcoma	0.00275	0.0254	CbGeAlD
Acetaminophen—PTGS2—periosteum—sarcoma	0.00266	0.0245	CbGeAlD
Acetaminophen—SULT1A1—hematopoietic system—sarcoma	0.00262	0.0242	CbGeAlD
Acetaminophen—SULT1E1—lymphoid tissue—sarcoma	0.00214	0.0198	CbGeAlD
Acetaminophen—PTGS2—leg—sarcoma	0.00212	0.0195	CbGeAlD
Acetaminophen—UGT1A10—liver—sarcoma	0.00197	0.0182	CbGeAlD
Acetaminophen—UGT1A6—testis—sarcoma	0.00194	0.0179	CbGeAlD
Acetaminophen—PTGS2—hindlimb—sarcoma	0.00189	0.0175	CbGeAlD
Acetaminophen—PTGS2—cartilage tissue—sarcoma	0.00186	0.0172	CbGeAlD
Acetaminophen—UGT1A6—liver—sarcoma	0.00184	0.0169	CbGeAlD
Acetaminophen—NAT2—liver—sarcoma	0.00184	0.0169	CbGeAlD
Acetaminophen—SULT2A1—testis—sarcoma	0.00181	0.0167	CbGeAlD
Acetaminophen—SULT1A1—tendon—sarcoma	0.00173	0.016	CbGeAlD
Acetaminophen—SULT2A1—liver—sarcoma	0.00171	0.0158	CbGeAlD
Acetaminophen—SULT1E1—testis—sarcoma	0.00167	0.0154	CbGeAlD
Acetaminophen—PTGS2—appendage—sarcoma	0.00162	0.015	CbGeAlD
Acetaminophen—SULT1E1—liver—sarcoma	0.00158	0.0145	CbGeAlD
Acetaminophen—CNR1—testis—sarcoma	0.00156	0.0144	CbGeAlD
Acetaminophen—SULT1A1—testis—sarcoma	0.00143	0.0132	CbGeAlD
Acetaminophen—SULT1A1—liver—sarcoma	0.00136	0.0125	CbGeAlD
Acetaminophen—UGT1A1—hematopoietic system—sarcoma	0.00131	0.0121	CbGeAlD
Acetaminophen—SULT2A1—lymph node—sarcoma	0.00131	0.0121	CbGeAlD
Acetaminophen—UGT2B15—liver—sarcoma	0.00131	0.0121	CbGeAlD
Acetaminophen—TRPV1—testis—sarcoma	0.00126	0.0117	CbGeAlD
Acetaminophen—SULT1E1—lymph node—sarcoma	0.00121	0.0111	CbGeAlD
Acetaminophen—CYP2A6—seminal vesicle—sarcoma	0.00116	0.0107	CbGeAlD
Acetaminophen—CNR1—lymph node—sarcoma	0.00113	0.0104	CbGeAlD
Acetaminophen—SULT1A1—lymph node—sarcoma	0.00104	0.0096	CbGeAlD
Acetaminophen—PTGS1—endothelium—sarcoma	0.00102	0.00946	CbGeAlD
Acetaminophen—CYP2C8—mammary gland—sarcoma	0.00102	0.0094	CbGeAlD
Acetaminophen—UGT1A9—liver—sarcoma	0.000991	0.00915	CbGeAlD
Acetaminophen—PTGS2—endothelium—sarcoma	0.00098	0.00904	CbGeAlD
Acetaminophen—CYP2C9—mammary gland—sarcoma	0.000905	0.00835	CbGeAlD
Acetaminophen—UGT1A1—liver—sarcoma	0.00068	0.00627	CbGeAlD
Acetaminophen—CYP2C8—hematopoietic system—sarcoma	0.000621	0.00573	CbGeAlD
Acetaminophen—CYP1A2—hematopoietic system—sarcoma	0.000581	0.00536	CbGeAlD
Acetaminophen—CYP1A1—hematopoietic system—sarcoma	0.000573	0.00529	CbGeAlD
Acetaminophen—CYP2A6—liver—sarcoma	0.000573	0.00529	CbGeAlD
Acetaminophen—PTGS2—myometrium—sarcoma	0.00056	0.00517	CbGeAlD
Acetaminophen—CYP2C9—hematopoietic system—sarcoma	0.000551	0.00509	CbGeAlD
Acetaminophen—CYP2E1—seminal vesicle—sarcoma	0.00055	0.00507	CbGeAlD
Acetaminophen—PTGS2—embryo—sarcoma	0.000539	0.00497	CbGeAlD
Acetaminophen—PTGS1—seminal vesicle—sarcoma	0.00053	0.00489	CbGeAlD
Acetaminophen—CYP2E1—hematopoietic system—sarcoma	0.000522	0.00482	CbGeAlD
Acetaminophen—PTGS2—seminal vesicle—sarcoma	0.000506	0.00467	CbGeAlD
Acetaminophen—PTGS1—hematopoietic system—sarcoma	0.000503	0.00464	CbGeAlD
Acetaminophen—CYP1A1—skin of body—sarcoma	0.000498	0.0046	CbGeAlD
Acetaminophen—PTGS1—connective tissue—sarcoma	0.000485	0.00447	CbGeAlD
Acetaminophen—PTGS2—hematopoietic system—sarcoma	0.000481	0.00444	CbGeAlD
Acetaminophen—PTGS2—connective tissue—sarcoma	0.000463	0.00427	CbGeAlD
Acetaminophen—PTGS1—smooth muscle tissue—sarcoma	0.000443	0.00409	CbGeAlD
Acetaminophen—PTGS1—skin of body—sarcoma	0.000438	0.00404	CbGeAlD
Acetaminophen—CYP1A1—cardiac atrium—sarcoma	0.000435	0.00401	CbGeAlD
Acetaminophen—CYP1A1—uterus—sarcoma	0.000433	0.00399	CbGeAlD
Acetaminophen—PTGS2—smooth muscle tissue—sarcoma	0.000424	0.00391	CbGeAlD
Acetaminophen—CYP3A4—hematopoietic system—sarcoma	0.00042	0.00388	CbGeAlD
Acetaminophen—PTGS2—skin of body—sarcoma	0.000418	0.00386	CbGeAlD
Acetaminophen—CYP2D6—hematopoietic system—sarcoma	0.000414	0.00382	CbGeAlD
Acetaminophen—PTGS1—cardiac atrium—sarcoma	0.000382	0.00353	CbGeAlD
Acetaminophen—PTGS1—uterus—sarcoma	0.00038	0.00351	CbGeAlD
Acetaminophen—CYP2E1—lymphoid tissue—sarcoma	0.000368	0.00339	CbGeAlD
Acetaminophen—PTGS2—uterus—sarcoma	0.000363	0.00335	CbGeAlD
Acetaminophen—ABCB1—myometrium—sarcoma	0.000347	0.0032	CbGeAlD
Acetaminophen—CYP2E1—tendon—sarcoma	0.000346	0.00319	CbGeAlD
Acetaminophen—CYP2C8—testis—sarcoma	0.00034	0.00314	CbGeAlD
Acetaminophen—PTGS2—lymphoid tissue—sarcoma	0.000339	0.00313	CbGeAlD
Acetaminophen—ABCB1—embryo—sarcoma	0.000333	0.00308	CbGeAlD
Acetaminophen—PTGS1—tendon—sarcoma	0.000333	0.00307	CbGeAlD
Acetaminophen—CYP2C8—liver—sarcoma	0.000322	0.00297	CbGeAlD
Acetaminophen—PTGS2—tendon—sarcoma	0.000318	0.00294	CbGeAlD
Acetaminophen—ABCB1—seminal vesicle—sarcoma	0.000313	0.00289	CbGeAlD
Acetaminophen—PTGS2—bone marrow—sarcoma	0.000308	0.00285	CbGeAlD
Acetaminophen—Constipation—Vincristine—sarcoma	0.000301	0.0017	CcSEcCtD
Acetaminophen—Pain in extremity—Doxorubicin—sarcoma	0.000301	0.0017	CcSEcCtD
Acetaminophen—CYP1A2—liver—sarcoma	0.000301	0.00278	CbGeAlD
Acetaminophen—Decreased appetite—Mitoxantrone—sarcoma	0.000298	0.00169	CcSEcCtD
Acetaminophen—Chest pain—Etoposide—sarcoma	0.000298	0.00168	CcSEcCtD
Acetaminophen—ABCB1—hematopoietic system—sarcoma	0.000298	0.00275	CbGeAlD
Acetaminophen—CYP1A1—liver—sarcoma	0.000297	0.00274	CbGeAlD
Acetaminophen—Hypokalaemia—Epirubicin—sarcoma	0.000296	0.00168	CcSEcCtD
Acetaminophen—Fatigue—Mitoxantrone—sarcoma	0.000296	0.00167	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000296	0.00167	CcSEcCtD
Acetaminophen—Discomfort—Etoposide—sarcoma	0.000294	0.00166	CcSEcCtD
Acetaminophen—Constipation—Mitoxantrone—sarcoma	0.000293	0.00166	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000293	0.00166	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000293	0.00166	CcSEcCtD
Acetaminophen—Hypersensitivity—Thiotepa—sarcoma	0.000293	0.00166	CcSEcCtD
Acetaminophen—Hypersensitivity—Dactinomycin—sarcoma	0.00029	0.00164	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Vincristine—sarcoma	0.000288	0.00163	CcSEcCtD
Acetaminophen—Confusional state—Etoposide—sarcoma	0.000288	0.00163	CcSEcCtD
Acetaminophen—Muscular weakness—Epirubicin—sarcoma	0.000287	0.00162	CcSEcCtD
Acetaminophen—CYP2E1—testis—sarcoma	0.000286	0.00264	CbGeAlD
Acetaminophen—CYP2C9—liver—sarcoma	0.000286	0.00264	CbGeAlD
Acetaminophen—Anaphylactic shock—Etoposide—sarcoma	0.000285	0.00161	CcSEcCtD
Acetaminophen—Asthenia—Thiotepa—sarcoma	0.000285	0.00161	CcSEcCtD
Acetaminophen—Abdominal distension—Epirubicin—sarcoma	0.000283	0.0016	CcSEcCtD
Acetaminophen—Asthenia—Dactinomycin—sarcoma	0.000283	0.0016	CcSEcCtD
Acetaminophen—Feeling abnormal—Mitoxantrone—sarcoma	0.000283	0.0016	CcSEcCtD
Acetaminophen—Asthma—Epirubicin—sarcoma	0.000281	0.00159	CcSEcCtD
Acetaminophen—Pruritus—Thiotepa—sarcoma	0.000281	0.00159	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000281	0.00159	CcSEcCtD
Acetaminophen—Thrombocytopenia—Etoposide—sarcoma	0.000279	0.00158	CcSEcCtD
Acetaminophen—Tachycardia—Etoposide—sarcoma	0.000279	0.00158	CcSEcCtD
Acetaminophen—Body temperature increased—Vincristine—sarcoma	0.000278	0.00158	CcSEcCtD
Acetaminophen—Abdominal pain—Vincristine—sarcoma	0.000278	0.00158	CcSEcCtD
Acetaminophen—Skin disorder—Etoposide—sarcoma	0.000277	0.00157	CcSEcCtD
Acetaminophen—Hyperhidrosis—Etoposide—sarcoma	0.000276	0.00156	CcSEcCtD
Acetaminophen—PTGS1—testis—sarcoma	0.000276	0.00255	CbGeAlD
Acetaminophen—Hypokalaemia—Doxorubicin—sarcoma	0.000274	0.00155	CcSEcCtD
Acetaminophen—Urticaria—Mitoxantrone—sarcoma	0.000273	0.00154	CcSEcCtD
Acetaminophen—Anorexia—Etoposide—sarcoma	0.000272	0.00154	CcSEcCtD
Acetaminophen—Diarrhoea—Thiotepa—sarcoma	0.000272	0.00154	CcSEcCtD
Acetaminophen—Body temperature increased—Mitoxantrone—sarcoma	0.000271	0.00153	CcSEcCtD
Acetaminophen—Abdominal pain—Mitoxantrone—sarcoma	0.000271	0.00153	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000271	0.00153	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000271	0.00153	CcSEcCtD
Acetaminophen—CYP2E1—liver—sarcoma	0.000271	0.0025	CbGeAlD
Acetaminophen—Diarrhoea—Dactinomycin—sarcoma	0.00027	0.00153	CcSEcCtD
Acetaminophen—Pancytopenia—Epirubicin—sarcoma	0.000267	0.00151	CcSEcCtD
Acetaminophen—Hypotension—Etoposide—sarcoma	0.000267	0.00151	CcSEcCtD
Acetaminophen—Muscular weakness—Doxorubicin—sarcoma	0.000266	0.0015	CcSEcCtD
Acetaminophen—Neutropenia—Epirubicin—sarcoma	0.000263	0.00149	CcSEcCtD
Acetaminophen—Dysuria—Epirubicin—sarcoma	0.000263	0.00149	CcSEcCtD
Acetaminophen—Dizziness—Thiotepa—sarcoma	0.000263	0.00149	CcSEcCtD
Acetaminophen—Abdominal distension—Doxorubicin—sarcoma	0.000262	0.00148	CcSEcCtD
Acetaminophen—Asthma—Doxorubicin—sarcoma	0.00026	0.00147	CcSEcCtD
Acetaminophen—Hypersensitivity—Vincristine—sarcoma	0.00026	0.00147	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Epirubicin—sarcoma	0.000257	0.00145	CcSEcCtD
Acetaminophen—Dyspnoea—Etoposide—sarcoma	0.000254	0.00144	CcSEcCtD
Acetaminophen—Hyperglycaemia—Epirubicin—sarcoma	0.000254	0.00144	CcSEcCtD
Acetaminophen—Somnolence—Etoposide—sarcoma	0.000254	0.00144	CcSEcCtD
Acetaminophen—Hypersensitivity—Mitoxantrone—sarcoma	0.000253	0.00143	CcSEcCtD
Acetaminophen—Asthenia—Vincristine—sarcoma	0.000253	0.00143	CcSEcCtD
Acetaminophen—Vomiting—Thiotepa—sarcoma	0.000253	0.00143	CcSEcCtD
Acetaminophen—Drowsiness—Epirubicin—sarcoma	0.000251	0.00142	CcSEcCtD
Acetaminophen—Vomiting—Dactinomycin—sarcoma	0.000251	0.00142	CcSEcCtD
Acetaminophen—Rash—Thiotepa—sarcoma	0.00025	0.00142	CcSEcCtD
Acetaminophen—Dermatitis—Thiotepa—sarcoma	0.00025	0.00142	CcSEcCtD
Acetaminophen—PTGS2—liver—sarcoma	0.000249	0.0023	CbGeAlD
Acetaminophen—Headache—Thiotepa—sarcoma	0.000249	0.00141	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000249	0.00141	CcSEcCtD
Acetaminophen—Rash—Dactinomycin—sarcoma	0.000249	0.00141	CcSEcCtD
Acetaminophen—Decreased appetite—Etoposide—sarcoma	0.000248	0.0014	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—sarcoma	0.000247	0.0014	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Etoposide—sarcoma	0.000246	0.00139	CcSEcCtD
Acetaminophen—Asthenia—Mitoxantrone—sarcoma	0.000246	0.00139	CcSEcCtD
Acetaminophen—Fatigue—Etoposide—sarcoma	0.000246	0.00139	CcSEcCtD
Acetaminophen—Constipation—Etoposide—sarcoma	0.000244	0.00138	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—sarcoma	0.000243	0.00138	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—sarcoma	0.000243	0.00138	CcSEcCtD
Acetaminophen—Diarrhoea—Vincristine—sarcoma	0.000241	0.00136	CcSEcCtD
Acetaminophen—Sweating—Epirubicin—sarcoma	0.00024	0.00136	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—sarcoma	0.000238	0.00134	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Epirubicin—sarcoma	0.000237	0.00134	CcSEcCtD
Acetaminophen—Nausea—Thiotepa—sarcoma	0.000236	0.00134	CcSEcCtD
Acetaminophen—Feeling abnormal—Etoposide—sarcoma	0.000235	0.00133	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—sarcoma	0.000235	0.00133	CcSEcCtD
Acetaminophen—Diarrhoea—Mitoxantrone—sarcoma	0.000235	0.00133	CcSEcCtD
Acetaminophen—Nausea—Dactinomycin—sarcoma	0.000234	0.00133	CcSEcCtD
Acetaminophen—Agranulocytosis—Epirubicin—sarcoma	0.000234	0.00132	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Etoposide—sarcoma	0.000233	0.00132	CcSEcCtD
Acetaminophen—Dizziness—Vincristine—sarcoma	0.000233	0.00132	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—sarcoma	0.000232	0.00131	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00023	0.0013	CcSEcCtD
Acetaminophen—PTGS2—S1P1 pathway—PDGFRB—sarcoma	0.000229	0.0105	CbGpPWpGaD
Acetaminophen—CYP2A6—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000228	0.0104	CbGpPWpGaD
Acetaminophen—CYP1A1—lymph node—sarcoma	0.000228	0.0021	CbGeAlD
Acetaminophen—Urticaria—Etoposide—sarcoma	0.000227	0.00128	CcSEcCtD
Acetaminophen—CYP2D6—testis—sarcoma	0.000227	0.00209	CbGeAlD
Acetaminophen—Haemoglobin—Epirubicin—sarcoma	0.000226	0.00128	CcSEcCtD
Acetaminophen—Body temperature increased—Etoposide—sarcoma	0.000226	0.00128	CcSEcCtD
Acetaminophen—Abdominal pain—Etoposide—sarcoma	0.000226	0.00128	CcSEcCtD
Acetaminophen—Hepatitis—Epirubicin—sarcoma	0.000225	0.00127	CcSEcCtD
Acetaminophen—Haemorrhage—Epirubicin—sarcoma	0.000225	0.00127	CcSEcCtD
Acetaminophen—ABCB1—uterus—sarcoma	0.000225	0.00207	CbGeAlD
Acetaminophen—Vomiting—Vincristine—sarcoma	0.000224	0.00127	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—sarcoma	0.000222	0.00126	CcSEcCtD
Acetaminophen—Urinary tract disorder—Epirubicin—sarcoma	0.000222	0.00126	CcSEcCtD
Acetaminophen—Rash—Vincristine—sarcoma	0.000222	0.00126	CcSEcCtD
Acetaminophen—Dermatitis—Vincristine—sarcoma	0.000222	0.00126	CcSEcCtD
Acetaminophen—Oedema peripheral—Epirubicin—sarcoma	0.000222	0.00125	CcSEcCtD
Acetaminophen—Connective tissue disorder—Epirubicin—sarcoma	0.000221	0.00125	CcSEcCtD
Acetaminophen—Urethral disorder—Epirubicin—sarcoma	0.000221	0.00125	CcSEcCtD
Acetaminophen—Headache—Vincristine—sarcoma	0.000221	0.00125	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—sarcoma	0.000219	0.00124	CcSEcCtD
Acetaminophen—SULT2A1—Corticotropin-releasing hormone—CREB1—sarcoma	0.000219	0.0101	CbGpPWpGaD
Acetaminophen—Vomiting—Mitoxantrone—sarcoma	0.000218	0.00123	CcSEcCtD
Acetaminophen—CYP3A4—liver—sarcoma	0.000218	0.00201	CbGeAlD
Acetaminophen—Agranulocytosis—Doxorubicin—sarcoma	0.000217	0.00123	CcSEcCtD
Acetaminophen—Rash—Mitoxantrone—sarcoma	0.000216	0.00122	CcSEcCtD
Acetaminophen—Dermatitis—Mitoxantrone—sarcoma	0.000216	0.00122	CcSEcCtD
Acetaminophen—Headache—Mitoxantrone—sarcoma	0.000215	0.00122	CcSEcCtD
Acetaminophen—CYP2D6—liver—sarcoma	0.000214	0.00198	CbGeAlD
Acetaminophen—Erythema multiforme—Epirubicin—sarcoma	0.000213	0.0012	CcSEcCtD
Acetaminophen—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000211	0.00969	CbGpPWpGaD
Acetaminophen—Eye disorder—Epirubicin—sarcoma	0.00021	0.00119	CcSEcCtD
Acetaminophen—Hypersensitivity—Etoposide—sarcoma	0.00021	0.00119	CcSEcCtD
Acetaminophen—ABCB1—lymphoid tissue—sarcoma	0.000209	0.00193	CbGeAlD
Acetaminophen—Haemoglobin—Doxorubicin—sarcoma	0.000209	0.00118	CcSEcCtD
Acetaminophen—Nausea—Vincristine—sarcoma	0.000209	0.00118	CcSEcCtD
Acetaminophen—Cardiac disorder—Epirubicin—sarcoma	0.000209	0.00118	CcSEcCtD
Acetaminophen—Flushing—Epirubicin—sarcoma	0.000209	0.00118	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—sarcoma	0.000208	0.00118	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—sarcoma	0.000208	0.00118	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—sarcoma	0.000206	0.00116	CcSEcCtD
Acetaminophen—UGT1A6—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000205	0.00943	CbGpPWpGaD
Acetaminophen—Oedema peripheral—Doxorubicin—sarcoma	0.000205	0.00116	CcSEcCtD
Acetaminophen—Asthenia—Etoposide—sarcoma	0.000205	0.00116	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—sarcoma	0.000205	0.00116	CcSEcCtD
Acetaminophen—Angiopathy—Epirubicin—sarcoma	0.000204	0.00116	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—sarcoma	0.000204	0.00116	CcSEcCtD
Acetaminophen—Nausea—Mitoxantrone—sarcoma	0.000204	0.00115	CcSEcCtD
Acetaminophen—Immune system disorder—Epirubicin—sarcoma	0.000203	0.00115	CcSEcCtD
Acetaminophen—Mediastinal disorder—Epirubicin—sarcoma	0.000203	0.00115	CcSEcCtD
Acetaminophen—Chills—Epirubicin—sarcoma	0.000202	0.00114	CcSEcCtD
Acetaminophen—Pruritus—Etoposide—sarcoma	0.000202	0.00114	CcSEcCtD
Acetaminophen—PTGS1—lymph node—sarcoma	0.0002	0.00184	CbGeAlD
Acetaminophen—Mental disorder—Epirubicin—sarcoma	0.000197	0.00112	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—sarcoma	0.000197	0.00111	CcSEcCtD
Acetaminophen—Erythema—Epirubicin—sarcoma	0.000196	0.00111	CcSEcCtD
Acetaminophen—Malnutrition—Epirubicin—sarcoma	0.000196	0.00111	CcSEcCtD
Acetaminophen—Diarrhoea—Etoposide—sarcoma	0.000195	0.0011	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—sarcoma	0.000195	0.0011	CcSEcCtD
Acetaminophen—Cardiac disorder—Doxorubicin—sarcoma	0.000193	0.00109	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—sarcoma	0.000193	0.00109	CcSEcCtD
Acetaminophen—Tension—Epirubicin—sarcoma	0.000192	0.00109	CcSEcCtD
Acetaminophen—PTGS2—lymph node—sarcoma	0.000191	0.00176	CbGeAlD
Acetaminophen—ABCB1—bone marrow—sarcoma	0.000191	0.00176	CbGeAlD
Acetaminophen—Nervousness—Epirubicin—sarcoma	0.00019	0.00108	CcSEcCtD
Acetaminophen—PTGS2—S1P1 pathway—KDR—sarcoma	0.00019	0.0087	CbGpPWpGaD
Acetaminophen—Angiopathy—Doxorubicin—sarcoma	0.000189	0.00107	CcSEcCtD
Acetaminophen—Dizziness—Etoposide—sarcoma	0.000189	0.00107	CcSEcCtD
Acetaminophen—Muscle spasms—Epirubicin—sarcoma	0.000188	0.00107	CcSEcCtD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.000188	0.00864	CbGpPWpGaD
Acetaminophen—Immune system disorder—Doxorubicin—sarcoma	0.000188	0.00106	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—sarcoma	0.000188	0.00106	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—sarcoma	0.000187	0.00106	CcSEcCtD
Acetaminophen—Vision blurred—Epirubicin—sarcoma	0.000185	0.00105	CcSEcCtD
Acetaminophen—UGT1A6—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000184	0.00846	CbGpPWpGaD
Acetaminophen—Mental disorder—Doxorubicin—sarcoma	0.000183	0.00103	CcSEcCtD
Acetaminophen—Ill-defined disorder—Epirubicin—sarcoma	0.000182	0.00103	CcSEcCtD
Acetaminophen—Vomiting—Etoposide—sarcoma	0.000181	0.00103	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—sarcoma	0.000181	0.00103	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—sarcoma	0.000181	0.00103	CcSEcCtD
Acetaminophen—Anaemia—Epirubicin—sarcoma	0.000181	0.00102	CcSEcCtD
Acetaminophen—Agitation—Epirubicin—sarcoma	0.00018	0.00102	CcSEcCtD
Acetaminophen—Rash—Etoposide—sarcoma	0.00018	0.00102	CcSEcCtD
Acetaminophen—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.00018	0.00826	CbGpPWpGaD
Acetaminophen—Dermatitis—Etoposide—sarcoma	0.00018	0.00102	CcSEcCtD
Acetaminophen—Headache—Etoposide—sarcoma	0.000179	0.00101	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—sarcoma	0.000178	0.00101	CcSEcCtD
Acetaminophen—Malaise—Epirubicin—sarcoma	0.000177	0.001	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—sarcoma	0.000176	0.000997	CcSEcCtD
Acetaminophen—Leukopenia—Epirubicin—sarcoma	0.000175	0.000993	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—sarcoma	0.000174	0.000987	CcSEcCtD
Acetaminophen—Palpitations—Epirubicin—sarcoma	0.000173	0.00098	CcSEcCtD
Acetaminophen—Cough—Epirubicin—sarcoma	0.000171	0.000968	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—sarcoma	0.000171	0.000967	CcSEcCtD
Acetaminophen—CNR1—G alpha (i) signalling events—CXCR4—sarcoma	0.00017	0.00781	CbGpPWpGaD
Acetaminophen—Convulsion—Epirubicin—sarcoma	0.00017	0.000961	CcSEcCtD
Acetaminophen—Nausea—Etoposide—sarcoma	0.00017	0.000959	CcSEcCtD
Acetaminophen—Hypertension—Epirubicin—sarcoma	0.000169	0.000957	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—sarcoma	0.000168	0.000952	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—sarcoma	0.000168	0.000948	CcSEcCtD
Acetaminophen—Chest pain—Epirubicin—sarcoma	0.000167	0.000944	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—sarcoma	0.000167	0.000943	CcSEcCtD
Acetaminophen—Anxiety—Epirubicin—sarcoma	0.000166	0.000941	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000166	0.000938	CcSEcCtD
Acetaminophen—Discomfort—Epirubicin—sarcoma	0.000165	0.000933	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—sarcoma	0.000164	0.000925	CcSEcCtD
Acetaminophen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	0.000163	0.0075	CbGpPWpGaD
Acetaminophen—Dry mouth—Epirubicin—sarcoma	0.000163	0.000923	CcSEcCtD
Acetaminophen—ABCB1—testis—sarcoma	0.000163	0.0015	CbGeAlD
Acetaminophen—Leukopenia—Doxorubicin—sarcoma	0.000162	0.000918	CcSEcCtD
Acetaminophen—SULT2A1—Corticotropin-releasing hormone—IL2—sarcoma	0.000162	0.00743	CbGpPWpGaD
Acetaminophen—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000161	0.00741	CbGpPWpGaD
Acetaminophen—Confusional state—Epirubicin—sarcoma	0.000161	0.000913	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—sarcoma	0.00016	0.000907	CcSEcCtD
Acetaminophen—Anaphylactic shock—Epirubicin—sarcoma	0.00016	0.000905	CcSEcCtD
Acetaminophen—Oedema—Epirubicin—sarcoma	0.00016	0.000905	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—sarcoma	0.000158	0.000895	CcSEcCtD
Acetaminophen—CNR1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000158	0.00724	CbGpPWpGaD
Acetaminophen—Shock—Epirubicin—sarcoma	0.000157	0.00089	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—sarcoma	0.000157	0.000889	CcSEcCtD
Acetaminophen—Nervous system disorder—Epirubicin—sarcoma	0.000157	0.000888	CcSEcCtD
Acetaminophen—Thrombocytopenia—Epirubicin—sarcoma	0.000157	0.000886	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—sarcoma	0.000157	0.000886	CcSEcCtD
Acetaminophen—SULT2A1—Corticotropin-releasing hormone—CTNNB1—sarcoma	0.000156	0.00718	CbGpPWpGaD
Acetaminophen—Tachycardia—Epirubicin—sarcoma	0.000156	0.000883	CcSEcCtD
Acetaminophen—Skin disorder—Epirubicin—sarcoma	0.000155	0.000879	CcSEcCtD
Acetaminophen—Hyperhidrosis—Epirubicin—sarcoma	0.000155	0.000875	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—sarcoma	0.000154	0.000874	CcSEcCtD
Acetaminophen—ABCB1—liver—sarcoma	0.000154	0.00142	CbGeAlD
Acetaminophen—Anxiety—Doxorubicin—sarcoma	0.000154	0.000871	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000153	0.000868	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—sarcoma	0.000153	0.000863	CcSEcCtD
Acetaminophen—Anorexia—Epirubicin—sarcoma	0.000152	0.000863	CcSEcCtD
Acetaminophen—SULT2A1—E2F transcription factor network—MYC—sarcoma	0.000152	0.007	CbGpPWpGaD
Acetaminophen—Dry mouth—Doxorubicin—sarcoma	0.000151	0.000854	CcSEcCtD
Acetaminophen—Hypotension—Epirubicin—sarcoma	0.000149	0.000846	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—sarcoma	0.000149	0.000844	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—sarcoma	0.000148	0.000837	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—sarcoma	0.000148	0.000837	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—sarcoma	0.000146	0.000824	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—sarcoma	0.000145	0.000821	CcSEcCtD
Acetaminophen—CYP1A1—Melatonin metabolism and effects—FOXO1—sarcoma	0.000145	0.00666	CbGpPWpGaD
Acetaminophen—Thrombocytopenia—Doxorubicin—sarcoma	0.000145	0.00082	CcSEcCtD
Acetaminophen—Insomnia—Epirubicin—sarcoma	0.000145	0.000819	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—sarcoma	0.000144	0.000817	CcSEcCtD
Acetaminophen—UGT1A9—PPAR Alpha Pathway—CCND1—sarcoma	0.000144	0.00661	CbGpPWpGaD
Acetaminophen—Skin disorder—Doxorubicin—sarcoma	0.000144	0.000813	CcSEcCtD
Acetaminophen—CYP1A1—Estrogen Receptor Pathway—JUN—sarcoma	0.000144	0.0066	CbGpPWpGaD
Acetaminophen—Hyperhidrosis—Doxorubicin—sarcoma	0.000143	0.00081	CcSEcCtD
Acetaminophen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	0.000143	0.00655	CbGpPWpGaD
Acetaminophen—Dyspnoea—Epirubicin—sarcoma	0.000143	0.000807	CcSEcCtD
Acetaminophen—Somnolence—Epirubicin—sarcoma	0.000142	0.000805	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—sarcoma	0.000141	0.000798	CcSEcCtD
Acetaminophen—Dyspepsia—Epirubicin—sarcoma	0.000141	0.000797	CcSEcCtD
Acetaminophen—PTGS1—Selenium Micronutrient Network—HBA1—sarcoma	0.00014	0.00642	CbGpPWpGaD
Acetaminophen—Decreased appetite—Epirubicin—sarcoma	0.000139	0.000787	CcSEcCtD
Acetaminophen—PTGS2—C-MYB transcription factor network—CD34—sarcoma	0.000139	0.00638	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—MYOD1—sarcoma	0.000139	0.00638	CbGpPWpGaD
Acetaminophen—Hypotension—Doxorubicin—sarcoma	0.000138	0.000783	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Epirubicin—sarcoma	0.000138	0.000781	CcSEcCtD
Acetaminophen—Fatigue—Epirubicin—sarcoma	0.000138	0.00078	CcSEcCtD
Acetaminophen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	0.000137	0.0063	CbGpPWpGaD
Acetaminophen—Constipation—Epirubicin—sarcoma	0.000137	0.000774	CcSEcCtD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000135	0.00621	CbGpPWpGaD
Acetaminophen—CNR1—BDNF signaling pathway—CREB1—sarcoma	0.000135	0.00619	CbGpPWpGaD
Acetaminophen—Insomnia—Doxorubicin—sarcoma	0.000134	0.000757	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—sarcoma	0.000132	0.000747	CcSEcCtD
Acetaminophen—Feeling abnormal—Epirubicin—sarcoma	0.000132	0.000746	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—sarcoma	0.000132	0.000744	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Epirubicin—sarcoma	0.000131	0.00074	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—sarcoma	0.00013	0.000737	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—sarcoma	0.000129	0.000728	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000128	0.000723	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—sarcoma	0.000128	0.000722	CcSEcCtD
Acetaminophen—Urticaria—Epirubicin—sarcoma	0.000127	0.000719	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—sarcoma	0.000127	0.000716	CcSEcCtD
Acetaminophen—Abdominal pain—Epirubicin—sarcoma	0.000126	0.000715	CcSEcCtD
Acetaminophen—Body temperature increased—Epirubicin—sarcoma	0.000126	0.000715	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—sarcoma	0.000122	0.00069	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—sarcoma	0.000121	0.000685	CcSEcCtD
Acetaminophen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	0.00012	0.0055	CbGpPWpGaD
Acetaminophen—ABCB1—lymph node—sarcoma	0.000118	0.00109	CbGeAlD
Acetaminophen—Hypersensitivity—Epirubicin—sarcoma	0.000118	0.000667	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—sarcoma	0.000118	0.000665	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—sarcoma	0.000117	0.000662	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—sarcoma	0.000117	0.000662	CcSEcCtD
Acetaminophen—UGT1A9—PPAR Alpha Pathway—MYC—sarcoma	0.000116	0.0053	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000115	0.00528	CbGpPWpGaD
Acetaminophen—Asthenia—Epirubicin—sarcoma	0.000115	0.000649	CcSEcCtD
Acetaminophen—Pruritus—Epirubicin—sarcoma	0.000113	0.00064	CcSEcCtD
Acetaminophen—PTGS2—Selenium Micronutrient Network—HBA1—sarcoma	0.000111	0.00509	CbGpPWpGaD
Acetaminophen—Diarrhoea—Epirubicin—sarcoma	0.000109	0.000619	CcSEcCtD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000109	0.00501	CbGpPWpGaD
Acetaminophen—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	0.000109	0.00501	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Doxorubicin—sarcoma	0.000109	0.000617	CcSEcCtD
Acetaminophen—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000107	0.00491	CbGpPWpGaD
Acetaminophen—Asthenia—Doxorubicin—sarcoma	0.000106	0.000601	CcSEcCtD
Acetaminophen—Dizziness—Epirubicin—sarcoma	0.000106	0.000599	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—sarcoma	0.000105	0.000592	CcSEcCtD
Acetaminophen—PTGS2—S1P1 pathway—VEGFA—sarcoma	0.000104	0.00479	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CXCR4—sarcoma	0.000103	0.00473	CbGpPWpGaD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.000102	0.00468	CbGpPWpGaD
Acetaminophen—Vomiting—Epirubicin—sarcoma	0.000102	0.000575	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—sarcoma	0.000101	0.000573	CcSEcCtD
Acetaminophen—Rash—Epirubicin—sarcoma	0.000101	0.000571	CcSEcCtD
Acetaminophen—Dermatitis—Epirubicin—sarcoma	0.000101	0.00057	CcSEcCtD
Acetaminophen—Headache—Epirubicin—sarcoma	0.0001	0.000567	CcSEcCtD
Acetaminophen—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.0001	0.00459	CbGpPWpGaD
Acetaminophen—Dizziness—Doxorubicin—sarcoma	9.79e-05	0.000554	CcSEcCtD
Acetaminophen—CNR1—BDNF signaling pathway—JUN—sarcoma	9.69e-05	0.00445	CbGpPWpGaD
Acetaminophen—CNR1—BDNF signaling pathway—CTNNB1—sarcoma	9.62e-05	0.00442	CbGpPWpGaD
Acetaminophen—Nausea—Epirubicin—sarcoma	9.5e-05	0.000538	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—sarcoma	9.41e-05	0.000532	CcSEcCtD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	9.36e-05	0.0043	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	9.36e-05	0.0043	CbGpPWpGaD
Acetaminophen—Rash—Doxorubicin—sarcoma	9.33e-05	0.000528	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—sarcoma	9.32e-05	0.000528	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—sarcoma	9.27e-05	0.000525	CcSEcCtD
Acetaminophen—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	9.25e-05	0.00424	CbGpPWpGaD
Acetaminophen—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	9.16e-05	0.00421	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	9.1e-05	0.00418	CbGpPWpGaD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	9.1e-05	0.00418	CbGpPWpGaD
Acetaminophen—Nausea—Doxorubicin—sarcoma	8.79e-05	0.000497	CcSEcCtD
Acetaminophen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—sarcoma	8.76e-05	0.00402	CbGpPWpGaD
Acetaminophen—CNR1—BDNF signaling pathway—SRC—sarcoma	8.69e-05	0.00399	CbGpPWpGaD
Acetaminophen—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—sarcoma	8.52e-05	0.00391	CbGpPWpGaD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	8.17e-05	0.00375	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	8.17e-05	0.00375	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	8.12e-05	0.00373	CbGpPWpGaD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	7.6e-05	0.00349	CbGpPWpGaD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	7.48e-05	0.00343	CbGpPWpGaD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	7.33e-05	0.00337	CbGpPWpGaD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	7.16e-05	0.00329	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	7.16e-05	0.00329	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—ENO2—sarcoma	6.86e-05	0.00315	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—HBA1—sarcoma	6.82e-05	0.00313	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	6.7e-05	0.00307	CbGpPWpGaD
Acetaminophen—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	6.59e-05	0.00303	CbGpPWpGaD
Acetaminophen—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	6.38e-05	0.00293	CbGpPWpGaD
Acetaminophen—CNR1—BDNF signaling pathway—HRAS—sarcoma	6.12e-05	0.00281	CbGpPWpGaD
Acetaminophen—CYP2A6—Fluoropyrimidine Activity—TP53—sarcoma	6.04e-05	0.00277	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—ENO2—sarcoma	6.04e-05	0.00277	CbGpPWpGaD
Acetaminophen—CYP1A1—Tryptophan metabolism—MDM2—sarcoma	6.02e-05	0.00276	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—HBA1—sarcoma	6e-05	0.00276	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PLCG1—sarcoma	5.82e-05	0.00267	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CXCR4—sarcoma	5.82e-05	0.00267	CbGpPWpGaD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	5.8e-05	0.00266	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	5.67e-05	0.0026	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	5.51e-05	0.00253	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	5.38e-05	0.00247	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—KIT—sarcoma	5.32e-05	0.00244	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—SRC—sarcoma	5.28e-05	0.00243	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CXCR4—sarcoma	5.28e-05	0.00243	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	5.23e-05	0.0024	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—ENO2—sarcoma	5.2e-05	0.00239	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—HBA1—sarcoma	5.17e-05	0.00237	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	5.15e-05	0.00236	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PLCG1—sarcoma	5.13e-05	0.00235	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—PDGFRA—sarcoma	5.1e-05	0.00234	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	5.08e-05	0.00233	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—ENO2—sarcoma	4.96e-05	0.00228	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—HBA1—sarcoma	4.93e-05	0.00226	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TLE1—sarcoma	4.9e-05	0.00225	CbGpPWpGaD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	4.84e-05	0.00222	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	4.75e-05	0.00218	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—MYC—sarcoma	4.74e-05	0.00217	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—SRC—sarcoma	4.69e-05	0.00215	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	4.69e-05	0.00215	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—ENO2—sarcoma	4.66e-05	0.00214	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—HBA1—sarcoma	4.63e-05	0.00213	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	4.63e-05	0.00213	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	4.57e-05	0.0021	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	4.51e-05	0.00207	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PLCG1—sarcoma	4.41e-05	0.00203	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	4.38e-05	0.00201	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	4.35e-05	0.002	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PLCG1—sarcoma	4.21e-05	0.00193	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—MYC—sarcoma	4.2e-05	0.00193	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—VEGFC—sarcoma	4.13e-05	0.0019	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	4.11e-05	0.00189	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	4.11e-05	0.00189	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PLCG1—sarcoma	3.96e-05	0.00182	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—ENO2—sarcoma	3.89e-05	0.00179	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.88e-05	0.00178	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—HBA1—sarcoma	3.87e-05	0.00178	CbGpPWpGaD
Acetaminophen—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	3.84e-05	0.00176	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.72e-05	0.00171	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—CCND1—sarcoma	3.65e-05	0.00167	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.55e-05	0.00163	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	3.43e-05	0.00157	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	3.33e-05	0.00153	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FLT1—sarcoma	3.3e-05	0.00152	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PLCG1—sarcoma	3.3e-05	0.00152	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.3e-05	0.00152	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PLCG1—sarcoma	3.25e-05	0.00149	CbGpPWpGaD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.19e-05	0.00147	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—NRAS—sarcoma	3.14e-05	0.00144	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	3.13e-05	0.00144	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CXCR4—sarcoma	3.12e-05	0.00143	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—ATF1—sarcoma	3.09e-05	0.00142	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	2.99e-05	0.00137	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	2.99e-05	0.00137	CbGpPWpGaD
Acetaminophen—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	2.96e-05	0.00136	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—MYC—sarcoma	2.93e-05	0.00134	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	2.91e-05	0.00134	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	2.88e-05	0.00132	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IL2—sarcoma	2.85e-05	0.00131	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CREB1—sarcoma	2.83e-05	0.0013	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IL2—sarcoma	2.79e-05	0.00128	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CCND1—sarcoma	2.78e-05	0.00128	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.73e-05	0.00126	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	2.7e-05	0.00124	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	2.68e-05	0.00123	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.62e-05	0.0012	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	2.62e-05	0.0012	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	2.62e-05	0.0012	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2.52e-05	0.00116	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	2.48e-05	0.00114	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IGF1R—sarcoma	2.42e-05	0.00111	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—VEGFA—sarcoma	2.37e-05	0.00109	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FOXO1—sarcoma	2.3e-05	0.00106	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—IL2—sarcoma	2.3e-05	0.00106	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PDGFRB—sarcoma	2.3e-05	0.00106	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	2.3e-05	0.00105	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PDGFRA—sarcoma	2.26e-05	0.00104	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—MYC—sarcoma	2.23e-05	0.00102	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—EGFR—sarcoma	2.18e-05	0.001	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.17e-05	0.000996	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.1e-05	0.000966	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—IL2—sarcoma	2.09e-05	0.00096	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KDR—sarcoma	1.91e-05	0.000875	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.89e-05	0.000868	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.89e-05	0.000866	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.87e-05	0.00086	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.86e-05	0.000854	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—sarcoma	1.83e-05	0.00084	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KIT—sarcoma	1.76e-05	0.000806	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—NRAS—sarcoma	1.76e-05	0.000806	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ENO2—sarcoma	1.73e-05	0.000793	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ENO2—sarcoma	1.73e-05	0.000793	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—HBA1—sarcoma	1.72e-05	0.000788	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—HBA1—sarcoma	1.72e-05	0.000788	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TLE1—sarcoma	1.71e-05	0.000784	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.69e-05	0.000777	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CREB1—sarcoma	1.67e-05	0.000767	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.65e-05	0.000757	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—EGFR—sarcoma	1.6e-05	0.000735	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NPM1—sarcoma	1.54e-05	0.000707	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.54e-05	0.000706	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.52e-05	0.000696	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—KRAS—sarcoma	1.51e-05	0.000694	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.48e-05	0.000681	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PLCG1—sarcoma	1.46e-05	0.000672	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PLCG1—sarcoma	1.46e-05	0.000672	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ENO2—sarcoma	1.41e-05	0.000646	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.4e-05	0.000643	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—HBA1—sarcoma	1.4e-05	0.000642	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MDM2—sarcoma	1.38e-05	0.000635	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.34e-05	0.000615	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.34e-05	0.000614	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ENO2—sarcoma	1.33e-05	0.000612	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ENO2—sarcoma	1.33e-05	0.000611	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.33e-05	0.000609	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—HBA1—sarcoma	1.32e-05	0.000607	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—HRAS—sarcoma	1.28e-05	0.00059	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.25e-05	0.000572	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL2—sarcoma	1.24e-05	0.000567	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCND1—sarcoma	1.2e-05	0.000553	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—JUN—sarcoma	1.2e-05	0.000552	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.2e-05	0.000551	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PLCG1—sarcoma	1.19e-05	0.000548	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CTNNB1—sarcoma	1.19e-05	0.000548	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.17e-05	0.000536	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PLCG1—sarcoma	1.13e-05	0.00052	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PLCG1—sarcoma	1.13e-05	0.000518	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ENO2—sarcoma	1.12e-05	0.000513	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—HBA1—sarcoma	1.11e-05	0.00051	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CXCR4—sarcoma	1.09e-05	0.000499	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SRC—sarcoma	1.08e-05	0.000495	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.07e-05	0.000494	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ENO2—sarcoma	1.05e-05	0.000483	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.05e-05	0.000483	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—VEGFA—sarcoma	1.05e-05	0.000482	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—HBA1—sarcoma	1.04e-05	0.00048	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NRAS—sarcoma	1.04e-05	0.000476	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.93e-06	0.000456	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ENO2—sarcoma	9.91e-06	0.000455	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—HBA1—sarcoma	9.85e-06	0.000452	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MYC—sarcoma	9.66e-06	0.000444	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PLCG1—sarcoma	9.48e-06	0.000435	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—EGFR—sarcoma	9.45e-06	0.000434	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ENO2—sarcoma	9.09e-06	0.000417	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—HBA1—sarcoma	9.03e-06	0.000415	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KRAS—sarcoma	8.93e-06	0.00041	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PLCG1—sarcoma	8.92e-06	0.00041	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.83e-06	0.000405	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PLCG1—sarcoma	8.41e-06	0.000386	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FOXO1—sarcoma	8.03e-06	0.000369	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PDGFRB—sarcoma	8.02e-06	0.000368	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—sarcoma	7.94e-06	0.000364	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ENO2—sarcoma	7.92e-06	0.000364	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PDGFRA—sarcoma	7.89e-06	0.000362	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—HBA1—sarcoma	7.87e-06	0.000361	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PLCG1—sarcoma	7.71e-06	0.000354	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HRAS—sarcoma	7.59e-06	0.000348	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ENO2—sarcoma	7.46e-06	0.000343	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—HBA1—sarcoma	7.42e-06	0.00034	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ENO2—sarcoma	7.4e-06	0.00034	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—HBA1—sarcoma	7.35e-06	0.000338	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PLCG1—sarcoma	6.72e-06	0.000308	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PLCG1—sarcoma	6.33e-06	0.000291	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ENO2—sarcoma	6.32e-06	0.00029	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—HBA1—sarcoma	6.28e-06	0.000288	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PLCG1—sarcoma	6.28e-06	0.000288	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KIT—sarcoma	6.12e-06	0.000281	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CREB1—sarcoma	5.82e-06	0.000267	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PLCG1—sarcoma	5.36e-06	0.000246	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ENO2—sarcoma	4.88e-06	0.000224	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—HBA1—sarcoma	4.85e-06	0.000223	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MDM2—sarcoma	4.82e-06	0.000221	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CTNNB1—sarcoma	4.16e-06	0.000191	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PLCG1—sarcoma	4.14e-06	0.00019	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—SRC—sarcoma	3.76e-06	0.000173	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NRAS—sarcoma	3.61e-06	0.000166	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MYC—sarcoma	3.37e-06	0.000155	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EGFR—sarcoma	3.29e-06	0.000151	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—sarcoma	3.11e-06	0.000143	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HRAS—sarcoma	2.64e-06	0.000121	CbGpPWpGaD
